StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Share Consolidation

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Jun 04, 2021 6:13pm

102 Views

Post# 33334753

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share Consolidation

LithLover wrote: And what benefit is a 2:1 split unless it gives them an opportunity to uplist? None. Just attempts by bashers to pile on and try to create doubt and fear to allow them to short and distort.

We see right through them so its ineffective as always and a waste of time.

Their families must be so proud that they attack a cancer detection company.

Liked2Think wrote: Rebecca says the reverse split wont occure before the Care deal is signed and done with.

Yes I am taking her for her word I suppose but the time table doesnt make sense.

Care agreed to the buyout yes at a higher SP but they would had done that believing the price woudl go up from there. They arent dumb people at Care. They know if they basically forced Stage to do the reverse split so they could get the price back up to a buck so that then Care woudl be given those shares they would actually lose value then.

Say they agreed to the buy out when the price was at a dollar.
Its at 50 cents today.
Say Stage does the 2:1 now and gives Care the number of shares at the new price
Its not like Care can sell those shares right away nor do they get all of the shares right away. Plus the extra extra they get for perfmormance milestones wouldnt happen.
Why wouldnt it happen? Because if Stage does the RS and then gives Care the shares it will destroy the SP. It will fall back to under 50 cents all over again.

So my question is to what benefit would it be to Care to have Stage do the RS before they give them the shares? Absolutely NOTHING.